While some topical herbal therapies may provide benefit for patients with AD, systemic herbal therapies do not provide significant benefit.

Young patients with atopic dermatitis prioritize different treatment goals and have varying preferences from their caregivers.

Apogee Therapeutics, Inc.'s APG777 shows promising week-16 efficacy and dosing potential, targeting the AT market. Click for ...

The atopic dermatitis therapeutics market is poised for steady growth, with revenues projected to rise from USD 15.43 billion in 2024 to USD 29.5 billion by 2033. This reflects a compound annual ...

Climate change and air pollution are growing threats to public health, and new research suggests they may also worsen atopic ...

When somebody's coming in that has a known diagnosis of atopic dermatitis or eczema and things are really revved up still, if ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Nektar Therapeutics (NASDAQ: NKTR) stock exploded nearly 157% following news that Rezpeg, the company’s experimental ...

Arcutis is financially strong, with over 30 months of cash runway. The atopic dermatitis market is large and shifting away ...

NKTR stock is up around 150% in today’s trading session following the recently announced positive results from its Phase 2b REZOLVE-AD study of rezpegaldesleukin ...

Ceramides aren’t just another moisturizer buzzword. From breakthrough lipid blends to ingestible rice-ceramide capsules, learn how these barrier-building molecules curb dryness, redness, and premature ...

Atopic dermatitis manifests differently on dark versus light skin, making equitable treatment challenging.